Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19- Infection with SARS-CoV-2 Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05731570
What this trial is testing

Cognitive Rehabilitation for People With Cognitive Covid19

Who this might be right for
Long Covid19
University College, London 78
Not applicableStudy completedNCT04794361
What this trial is testing

Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner

Who this might be right for
Covid19
Centre Hospitalier Universitaire de Nīmes 400
Large-scale testing (Phase 3)Study completedNCT05364242
What this trial is testing

VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Valneva Austria GmbH 178
Early research (Phase 1)Study completedNCT05385991
What this trial is testing

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

Who this might be right for
SARS-CoV-2 Infection
ACM Biolabs 38
Testing effectiveness (Phase 2)Study completedNCT04937543
What this trial is testing

Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19

Who this might be right for
Covid19
UPECLIN HC FM Botucatu Unesp 50
Testing effectiveness (Phase 2)Ended earlyNCT04449380
What this trial is testing

Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients

Who this might be right for
COVID-19 Virus Infection
Emanuele Bosi 56
Not applicableEnded earlyNCT04595903
What this trial is testing

Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device

Who this might be right for
COVID-19
Aethlon Medical Inc. 1
Not applicableStudy completedNCT04397523
What this trial is testing

Efficacy and Safety of COVID-19 Convalescent Plasma

Who this might be right for
Convalescent PlasmaCOVID-19SARS-CoV 2
Institute for Transfusion Medicine of RNM 200
Not applicableStudy completedNCT04479488
What this trial is testing

Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)

Who this might be right for
Covid19SARS-CoV Infection
Hospital Israelita Albert Einstein 1,587
Not applicableUnknownNCT03262051
What this trial is testing

Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot

Who this might be right for
Inflammation
University Hospital, Geneva 106
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Testing effectiveness (Phase 2)Study completedNCT05859919
What this trial is testing

Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of COVID-19

Who this might be right for
Patients With COVID-19
Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan 57
Not applicableStudy completedNCT04607941
What this trial is testing

Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19

Who this might be right for
Covid19
Institut Pasteur 766,818
Large-scale testing (Phase 3)UnknownNCT04824222
What this trial is testing

The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters

Who this might be right for
Covid19
Medical University of Warsaw 366
Not applicableStudy completedNCT04655612
What this trial is testing

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

Who this might be right for
COVID-19SARS-CoV InfectionRheumatoid Arthritis+3 more
University Hospital, Montpellier 5,000
Testing effectiveness (Phase 2)WithdrawnNCT05239975
What this trial is testing

The Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV2 Infection
Sinocelltech Ltd.
Very early researchStudy completedNCT04742595
What this trial is testing

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)UnknownNCT05173441
What this trial is testing

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

Who this might be right for
COVID-19
Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. 180
Large-scale testing (Phase 3)Study completedNCT05780281
What this trial is testing

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 367
Large-scale testing (Phase 3)Study completedNCT04600895
What this trial is testing

The Prevent Severe COVID-19 (PRESECO) Study

Who this might be right for
Covid19
Appili Therapeutics Inc. 1,187
Next Page